Gilead Sciences (GILD) Misses Q2 EPS by 34c; Guides In-Line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Gilead Sciences Announces Second Quarter and First Half 2020 Financial Results
July 30, 2020 4:01 PM EDTSecond Quarter and First Half 2020
- Second Quarter Product Sales of $5.1 billion -
- First Half Product Sales of $10.5 billion -
- Second Quarter GAAP Loss of $(2.66) per share -
- Second Quarter Non-GAAP Diluted EPS of $1.11 per share -
Revised Full Year 2020 Guidance
- Product Sales of $23 billion to $25 billion -
- Non-GAAP Diluted EPS... More
